GENAERA CORP
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Insider transactions
SEC Form 4 · most recent0 acquisitions2 disposalsnet −1.4M shares · last 2
| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Xmark Opportunity Partners, Llc10% owner | Jun 29, 2009 | Sell | 42,571 | $0.10 |
| Xmark Opportunity Partners, Llc10% owner | Jun 5, 2009 | Sell | 1.4M | $0.31 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Director / officer change · Other material eventJun 12, 2009
- Results of operationsJun 10, 2009
- Delisting / listing-standard notice · Other material eventMay 27, 2009
- Other material eventApr 29, 2009
- Entered a material agreement · Director / officer changeApr 28, 2009
- Entered a material agreement · Director / officer changeApr 3, 2009
- Other material eventMar 30, 2009
- Other material eventMar 10, 2009
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AGENAERA CORPORATION SCEDULE 13G.A.3Feb 16, 2010
- 4FORM 4Jul 1, 2009
- 25FORM 25Jun 22, 2009
- SC 13GSC13GJun 18, 2009
- 8-KJun 12, 2009
- 15-12GFORM 15Jun 12, 2009
- 8-KJun 10, 2009
- 4Jun 9, 2009
- 8-KMay 27, 2009
- DEFM14AGENAERA CORPMay 14, 2009
- PRER14AREVISED PRELIMINARY PROXY - GENAERA CORPMay 14, 2009
- SC 13GSCHEDULE 13GMay 6, 2009
- 8-KApr 29, 2009
- PRE 14AGENAERA CORPORATION - NOTICE OF SPECIAL MEETINGApr 28, 2009
- 8-KApr 28, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.